11.20.2023
Improve Outcomes
$1,415,567.00
36 months
A randomized crossover trial evaluating the effect of inhaled Technosphere Insulin versus rapid acting analogue insulin on exercise-induced hypoglycemia in adults with T1D using automated insulin delivery
A randomized crossover trial evaluating the effect of inhaled Technosphere Insulin versus rapid acting analogue insulin on exercise-induced hypoglycemia in adults with T1D using automated insulin delivery